dextrothyroxine has been researched along with Aura in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 2 (5.56) | 18.2507 |
| 2000's | 1 (2.78) | 29.6817 |
| 2010's | 17 (47.22) | 24.3611 |
| 2020's | 15 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Basanez, MG; Colebunders, R; Enyong, PA; Hendy, A; Mengnjo, MK; Nfor, LN; Ngarka, L; Njamnshi, AK; Njamnshi, WY; Palmer, D; Siewe Fodjo, JN; Vieri, MK | 1 |
| Domche, A; Efon-Ekangouo, A; Geiger, A; Kamgno, J; Lisongue-Tonga, E; Nana-Djeunga, HC; Nwane, P; Osei-Atweneboana, MY; Sumo, L | 1 |
| Amaral, LJ; Colebunders, R; Hadermann, A; Siewe Fodjo, JN; Van Cutsem, G | 1 |
| Löscher, W | 1 |
| Bhwana, D; Challe, DP; Colebunders, R; Dusabimana, A; Fodjo, JNS; Makunde, WH; Mhina, A; Mmbando, BP | 1 |
| Ambomatei, C; Mengnjo, MK; Nfor, LN; Ngarka, L; Njamnshi, AK; Njamnshi, WY; Siewe Fodjo, JN; Taryunyu Njamnshi, JN | 1 |
| Bhattacharyya, S; Coffeng, LE; Colebunders, R; Logora, MY; Siewe Fodjo, JN; Stolk, WA; Vinkeles Melchers, NVS; Vutha, A | 1 |
| Amaral, LJ; Bhwana, D; Colebunders, R; Francis, F; Hayuma, PM; Mhina, A; Mmbando, BP; Siewe Fodjo, JN | 1 |
| Amaral, LJ; Bol, YY; Carter, JY; Colebunders, R; Fodjo, JNS; Hadermann, A; Hopkins, A; Jada, SR; Lakwo, T; Logora, MY; Rovarini, J | 1 |
| Ameyaw, J; Ankrah, B; Antwi-Berko, D; Avarikame, FA; Babae, TN; Bamfo, JG; Bart-Plange, EJ; Basáñez, MG; Colebunders, R; Darko, VA; Donkoh, ES; Fodjo, JNS; Kudzordzi, PC; Ofori-Appiah, FO; Otabil, KB; Sakibu, RA; Schallig, HDFH | 1 |
| Abhafule, G; Colebunders, R; Dusabimana, A; Haesendonckx, S; Hotterbeekx, A; Jakwong, JM; Lokonda, R; Mandro, M; Meganck, J; Menon, S; Mukendi, D; Nakato, S; Nyisi, F; Siewe Fodjo, JN; Suykerbuyk, P; Wonya'Rossi, D | 1 |
| Colebunders, R; Gumisiriza, N; Hotterbeekx, A; Idro, R; Kaducu, J; Lakwo, T; Makumbi, I; Mbonye Kayitale, M; Mubiru, F; Opar, B; Siewe Fodjo, JN; Wamala, JF | 1 |
| Colebunders, R; Preux, PM; Remme, JHF; Siewe Fodjo, JN | 1 |
| Colebunders, R; Dierickx, S; Ekukole, S; Gryseels, C; Irani, J; Njamnshi, AK; O'Neill, S; Peeters Grietens, K; Ronse, M; Smekens, T; Tatah Ntaimah, P; Teh Monteh, C; Verdonck, K | 1 |
| Chandra, PP; Jain, S; Potschka, H; Tripathi, M; Vohora, D | 1 |
| Begon, M; Bonareri Osoro, C; Colebunders, R; Ensoy-Musoro, C; Falay, D; Kashama, JM; Komba, M; Laudisoit, A; Levick, B; Mandro, M; Suykerbuyk, P; Tagoto, A; Tepage, F | 1 |
| Diazgranados-Sanchez, JA | 1 |
| Moscote-Salazar, LR; Pinilla-Monsalve, GD | 1 |
| Colebunders, R; Greter, H; Kakorozya, A; Makunde, W; Matuja, W; Mmbando, B; Mnacho, M; Suykerbuyk, P | 1 |
| Colebunders, R; Greter, H; Hendy, A; Kakorozya, A; Makunde, WH; Matuja, W; Mmbando, BP; Mnacho, M; Suykerbuyk, P | 1 |
| Abd-Elfarag, G; Carter, JY; Colebunders, R; Lako, R; Logora, MY; Menon, S; Ojok, M; Songok, J; Wit, F | 1 |
| Hotterbeekx, A; Idro, R; Lakwo, T; Namale Ssonko, V; Oyet, W | 1 |
| Abd-Elfarag, G; Bhattacharyya, S; Colebunders, R; Ensoy-Musoro, C; Lako, R; Logora, MY; Menon, S; Ojok, M; Olore, PC; Puok, K; Y Carter, J | 1 |
| Bissek, AZ; Boussinesq, M; Chesnais, CB; Chokote, SE; Colebunders, R; Dema, F; Mengnjo, MK; Nfor, LN; Ngarka, L; Njamnshi, AK; Nkoro, G; Ntone, FE; Siewe Fodjo, JN; Sitouok, AT; Tabah, EN; Tatah, G | 1 |
| Amaechi, AA; Chimechefulam, L; Colebunders, R; Eriama-Joseph, AI; Ezenwa, CI; Ezike, MN; Ikpeama, C; Nwachukwu, O; Nwanjor, SO; Nwazor, EO; Nwoke, BEB; Nwoke, MO; Nwokeji, MC; Ogomaka, AI; Okeke, J; Onuoha, BC; Osahor, K; Siewe, JNF; Ukaga, CN | 1 |
| Cantey, PT; Sejvar, J | 1 |
| Akonda, I; Colebunders, R; Couvreur, S; Hotterbeekx, A; Kabutako, B; Laudisoit, A; Menon, S; Mukendi, D; Ndibmun, CN; Rotsaert, A; Siewe, JNF; Tepage, F | 1 |
| Bissek, AZ; Boullé, C; Boussinesq, M; Chesnais, CB; Colebunders, R; Dema, F; Kamgno, J; Lenou-Nanga, CG; Mengnjo, MK; Nana-Djeunga, HC; Njamnshi, AK; Siewe Fodjo, JN; Suykerbuyk, P | 1 |
| Abhafule, G; Anyolito, A; Colebunders, R; Hotterbeekx, A; Lokonda, R; Mandro, M; Menon, S; Mukendi, D; Nakato, S; Nyisi, F; Siewe Fodjo, JN; Tepage, F; Wonya'rossi, D | 1 |
| Basáñez, MG; Colebunders, R; Hopkins, A; Hotterbeekx, A; Kalinga, A; Lakwo, TL; Logora, MY; Siewe Fodjo, JN | 1 |
| Abatih, EN; Colebunders, R; Kabeya, J; Komba, M; Laudisoit, A; Levick, B; Mambandu, G; Mandro, M; Mokili, JL; Musinya, G; Rood, E; Tepage, F | 1 |
| Begon, M; Colebunders, R; Hoerauf, A; Laudisoit, A; Levick, B; Mambandu, G; Mandro, M; Mokili, JL; Mucinya, G; Pfarr, K; Reiter-Owona, I; Tepage, F | 1 |
| Twum-Danso, NA | 1 |
| Crichlow, EC; Kim, JS | 1 |
| Blizzard, TA; Dawson, GR; Fisher, MH; Meinke, PT; Michael, BF; Mrozik, H; Shoop, WL | 1 |
| Crawford, RD; Crichlow, EC; Mishra, PR | 1 |
6 review(s) available for dextrothyroxine and Aura
| Article | Year |
|---|---|
Onchocerciasis-associated epilepsy: an update and future perspectives.
Topics: Animals; Child; Epilepsy; Humans; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Seizures | 2023 |
Is the antiparasitic drug ivermectin a suitable candidate for the treatment of epilepsy?
Topics: Alcoholism; Animals; Antiparasitic Agents; COVID-19; Epilepsy; Humans; Ivermectin; Mammals | 2023 |
Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control.
Topics: Africa, Eastern; Africa, Western; Cote d'Ivoire; Epilepsy; Humans; Ivermectin; Onchocerciasis; Prevalence | 2020 |
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inducers; Dexamethasone; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Ivermectin; Lopinavir; Pyrazines; Ritonavir; SARS-CoV-2 | 2021 |
Neurological manifestations in Onchocerca volvulus infection: A review.
Topics: Africa; Africa South of the Sahara; Animals; Epilepsy; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis | 2019 |
Mass treatment of onchocerciasis with ivermectin: should people with epilepsy and/or growth-retardation syndromes be excluded?
Topics: Africa; Animals; Anthelmintics; Contraindications; Developing Countries; Endemic Diseases; Epilepsy; Growth Disorders; Humans; Incidence; Ivermectin; Onchocerciasis; Prevalence | 2004 |
2 trial(s) available for dextrothyroxine and Aura
| Article | Year |
|---|---|
'Slash and clear' vector control for onchocerciasis elimination and epilepsy prevention: a protocol of a cluster randomised trial in Cameroonian villages.
Topics: Child; Epilepsy; Humans; Incidence; Ivermectin; Onchocerciasis; Randomized Controlled Trials as Topic; Seroepidemiologic Studies | 2021 |
Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
Topics: Adolescent; Adult; Anticonvulsants; Antiparasitic Agents; Democratic Republic of the Congo; Drug Therapy, Combination; Epilepsy; Female; Humans; Ivermectin; Male; Onchocerciasis; Young Adult | 2020 |
28 other study(ies) available for dextrothyroxine and Aura
| Article | Year |
|---|---|
Prevalence of epilepsy in Ndom Health District (Littoral Region, Cameroon) after long-term ivermectin-based preventive chemotherapy for the control of onchocerciasis.
Topics: Adult; Cameroon; Cross-Sectional Studies; Epilepsy; Female; Humans; Ivermectin; Male; Onchocerciasis; Prevalence; Young Adult | 2022 |
Ivermectin treatment response in two rural villages with a high prevalence of onchocerciasis and epilepsy, Mahenge Tanzania.
Topics: Animals; Epilepsy; Follow-Up Studies; Humans; Ivermectin; Microfilariae; Onchocerca volvulus; Onchocerciasis; Prevalence; Tanzania; Treatment Outcome | 2022 |
Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon.
Topics: Adult; Cameroon; Epilepsy; Female; Humans; Ivermectin; Male; Onchocerciasis; Prevalence | 2023 |
Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness.
Topics: Adolescent; Animals; Blindness; Child; Child, Preschool; Epilepsy; Female; Humans; Ivermectin; Onchocerca volvulus; Onchocerciasis; Onchocerciasis, Ocular; Prevalence; Simuliidae; South Sudan | 2023 |
Impact of a bi-annual community-directed treatment with ivermectin programme on the incidence of epilepsy in an onchocerciasis-endemic area of Mahenge, Tanzania: A population-based prospective study.
Topics: Adolescent; Antiparasitic Agents; Child; Epilepsy; Humans; Incidence; Ivermectin; Nodding Syndrome; Onchocerciasis; Prevalence; Prospective Studies; Tanzania | 2023 |
Effect of onchocerciasis elimination measures on the incidence of epilepsy in Maridi, South Sudan: a 3-year longitudinal, prospective, population-based study.
Topics: Adolescent; Adult; Child; Epilepsy; Female; Humans; Incidence; Ivermectin; Male; Nodding Syndrome; Onchocerciasis; Prevalence; Prospective Studies; South Sudan; Young Adult | 2023 |
Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin.
Topics: Adult; Animals; Cross-Sectional Studies; Epilepsy; Female; Ghana; Humans; Intestinal Volvulus; Ivermectin; Male; Mass Drug Administration; Microfilariae; Onchocerciasis; Prevalence; Seroepidemiologic Studies | 2023 |
Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures.
Topics: Adolescent; Animals; Antiparasitic Agents; Child; Endemic Diseases; Epilepsy; Female; Humans; Incidence; Ivermectin; Male; Nodding Syndrome; Onchocerca volvulus; Onchocerciasis; Prevalence; Uganda; Young Adult | 2020 |
In pursuit of a cure: The plural therapeutic landscape of onchocerciasis-associated epilepsy in Cameroon - A mixed methods study.
Topics: Adult; Cameroon; Cross-Sectional Studies; Epilepsy; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Socioeconomic Factors; Surveys and Questionnaires | 2021 |
High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.
Topics: Adolescent; Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; Antiparasitic Agents; Case-Control Studies; Child; Child, Preschool; Democratic Republic of the Congo; Demography; Endemic Diseases; Epilepsy; Family Characteristics; Female; Humans; Infant; Infant, Newborn; Ivermectin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Onchocerciasis; Prevalence; Prospective Studies; Risk Factors; Young Adult | 2017 |
[Potential interactions with ivermectin as adjuvant therapy for refractory epilepsy. Reply].
Topics: Combined Modality Therapy; Drug Resistant Epilepsy; Epilepsy; Humans; Ivermectin | 2018 |
[Potential interactions with ivermectin as adjuvant therapy for refractory epilepsy].
Topics: Combined Modality Therapy; Drug Resistant Epilepsy; Epilepsy; Humans; Ivermectin | 2018 |
Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.
Topics: Adult; Antiparasitic Agents; Child; Cross-Sectional Studies; Endemic Diseases; Epilepsy; Humans; Incidence; Ivermectin; Onchocerciasis; Prevalence; Public Health; Tanzania; Young Adult | 2018 |
High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
Topics: Adolescent; Adult; Animals; Child; Epilepsy; Female; Humans; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Rural Population; Tanzania; Young Adult | 2018 |
The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.
Topics: Adolescent; Antiparasitic Agents; Child; Child, Preschool; Endemic Diseases; Epilepsy; Female; Humans; Incidence; Ivermectin; Male; Nodding Syndrome; Onchocerciasis; Prevalence; Public Health; South Sudan | 2018 |
High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan: A community-based survey.
Topics: Adolescent; Adult; Antiparasitic Agents; Child; Child, Preschool; Endemic Diseases; Epilepsy; Female; Geography, Medical; Humans; Incidence; Infant; Infant, Newborn; Ivermectin; Male; Onchocerciasis; Prevalence; Risk Factors; Rivers; South Sudan; Young Adult | 2018 |
Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
Topics: Adolescent; Adult; Antiparasitic Agents; Cameroon; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Ivermectin; Male; Middle Aged; Onchocerciasis; Prevalence; Retrospective Studies; Rivers; Young Adult | 2018 |
Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparasitic Agents; Child; Child, Preschool; Cross-Sectional Studies; Epilepsy; Female; Humans; Infant; Infant, Newborn; Ivermectin; Male; Middle Aged; Nigeria; Onchocerciasis; Prevalence; Young Adult | 2019 |
Onchocerciasis associated epilepsy-A question of causality.
Topics: Democratic Republic of the Congo; Epilepsy; Humans; Ivermectin; Onchocerciasis; Prevalence | 2019 |
High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.
Topics: Adolescent; Adult; Animals; Antibodies, Helminth; Case-Control Studies; Child; Child, Preschool; Democratic Republic of the Congo; Epilepsy; Female; Focus Groups; Humans; Immunoglobulin G; Ivermectin; Male; Onchocerca volvulus; Onchocerciasis; Prevalence; Rural Population; Seizures; Young Adult | 2019 |
Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon.
Topics: Adolescent; Adult; Antinematodal Agents; Cameroon; Child; Epilepsy; Female; Humans; Incidence; Ivermectin; Male; Mass Drug Administration; Onchocerciasis; Prevalence; Young Adult | 2019 |
Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Topics: Adolescent; Adult; Aged; Animals; Antiparasitic Agents; Child; Child, Preschool; Cross-Sectional Studies; Democratic Republic of the Congo; Endemic Diseases; Epilepsy; Female; Humans; Infant; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Qualitative Research; Randomized Controlled Trials as Topic; Seizures; Severity of Illness Index; Young Adult | 2019 |
From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
Topics: Antiparasitic Agents; Blindness; Cost of Illness; Disease Eradication; Epilepsy; Humans; Ivermectin; Neglected Diseases; Onchocerciasis; Onchocerciasis, Ocular; Rivers | 2019 |
Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo.
Topics: Adolescent; Adult; Age Distribution; Animals; Child; Child, Preschool; Democratic Republic of the Congo; Endemic Diseases; Epilepsy; Female; Filaricides; Humans; Ivermectin; Male; Middle Aged; Neglected Diseases; Onchocerca volvulus; Onchocerciasis; Prevalence; Risk Factors; Rivers; Simuliidae; Young Adult | 2016 |
Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
Topics: Adolescent; Adult; Animals; Case-Control Studies; Child; Child, Preschool; Democratic Republic of the Congo; Epilepsy; Female; Humans; Ivermectin; Male; Middle Aged; Onchocerca volvulus; Onchocerciasis; Prevalence; Risk Factors; Simuliidae; Young Adult | 2016 |
Clinical signs of ivermectin toxicity and the efficacy of antigabaergic convulsants as antidotes for ivermectin poisoning in epileptic chickens.
Topics: Animals; Antidotes; Carbolines; Chickens; Epilepsy; GABA Antagonists; Ivermectin; Pentylenetetrazole; Picrotoxin; Poultry Diseases | 1995 |
Synthesis of gem-difluoro-avermectin derivatives: potent anthelmintic and anticonvulsant agents.
Topics: Animals; Anthelmintics; Anticonvulsants; Epilepsy; Ivermectin; Mice; Molecular Structure | 1998 |
Anticonvulsant effects of ivermectin in genetically-epileptic chickens.
Topics: Animals; Anticonvulsants; Chickens; Diazepam; Epilepsy; Ivermectin; Mutation; Photic Stimulation; Poultry Diseases | 1986 |